Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T13:35:38.975Z.
Calculation as of: 2026-10-06T13:35:38.975Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 533c4696450707580a389d0c8167e09da333cd728c1767827588ef029f48caf5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$1.42B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.23B
Price/FCF Ratio
24.28
TTM Avg
28.25
3Y Avg
29.31
5Y Avg
46.12
Market Cap
$1.22B
Price/FCF Ratio
24.57
TTM Avg
2775.83
3Y Avg
1287.19
5Y Avg
1287.19
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $1.33B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.34B | N/A | N/A | N/A | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.35B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.38B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.23B | 24.28 | 28.25 | 29.31 | 46.12 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 24.57 | 2775.83 | 1287.19 | 1287.19 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
